WallStSmart

SYLA Technologies Co., Ltd. American Depositary Shares (SYT)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

SYLA Technologies Co., Ltd. American Depositary Shares generates 11824% more annual revenue ($30.87B vs $258.90M). SYT leads profitability with a 3.6% profit margin vs -15.5%. SYT earns a higher WallStSmart Score of 60/100 (C).

SYT

Buy

60

out of 100

Grade: C

Growth: 10.0Profit: 5.5Value: 6.7Quality: 5.5
Piotroski: 5/9Altman Z: 1.55

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for SYT.

ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

SYT4 strengths · Avg: 10.0/10
P/E RatioValuation
9.0x10/10

Attractively priced relative to earnings

Price/BookValuation
0.0x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
51.3%10/10

Revenue surging 51.3% year-over-year

EPS GrowthGrowth
144.9%10/10

Earnings expanding 144.9% YoY

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

SYT4 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.554/10

Distress zone — elevated risk

Market CapQuality
$60.16M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
3.6%3/10

3.6% margin — thin

Free Cash FlowQuality
$-9.93B2/10

Negative free cash flow — burning cash

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : SYT

The strongest argument for SYT centers on P/E Ratio, Price/Book, Revenue Growth. Revenue growth of 51.3% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : SYT

The primary concerns for SYT are Altman Z-Score, Market Cap, Profit Margin. Debt-to-equity of 3.36 is elevated, increasing financial risk. Thin 3.6% margins leave little buffer for downturns.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

SYT carries more volatility with a beta of 2.41 — expect wider price swings.

SYT is growing revenue faster at 51.3% — sustainability is the question.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

SYT scores higher overall (60/100 vs 41/100) and 51.3% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

SYLA Technologies Co., Ltd. American Depositary Shares

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Syngenta AG, an agribusiness company, participates in the crop protection, seed and lawn and garden markets globally.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?